Submitted By: Veena On July 15, 2024 09:07 PM IST
Advertisement
Hin Khan is all set to resume work and shoot where she writes an inspirational note.
My first work assignment after my diagnosis..
Walking the talk is challenging, especially when facing life’s biggest challenges. So, give yourself a break on bad days; it’s okay… you deserve it. However, don’t forget to live your life on the good days, no matter how few they are. These days still hold importance. Accept the change, embrace the difference, and NORMALISE it.
I look forward to the good days because I get to do what I love: Work. I love my work. I live my dreams when I’m working, and that is my greatest motivation. I want to keep working. Many people work regular jobs during their treatment without issues, and I am no different. I met a few in these months and trust me it changed my perspective.
FYI I am undergoing a treatment but I am not always in the hospital..so to all you people out there, Let’s NORMALISE working and if you have the strength and energy, do whatever makes you HAPPY.
And to all you beautiful people who are battling this disease,
Remember, it’s your story; it’s your life. You decide what to make of it. Don’t give up and find what you love doing. Your work, your passion—if you don’t know what it is, invent it. But remember to give yourself the healing you deserve. Coz doing what you love is also Healing.
ACCEPT, EMBRACE and NORMALISE IT
Anupama: Strange six months with new look for Anupama Vanraj Anuj Get ready for some exciting twists and turns in the popular Star Plus serial Anupama boasts a talented cast including ......
Yeh Rishta Kya Kehlata Hai (YRKKH): Rohit's return to block Ruhi barging in Armaan's life The upcoming episode of Star Plus popular serial Yeh Rishta Kya Kehlata Hai will showcase interesting ......
Yeh Rishta Kya Kehlata Hai (YRKKH): Romit Raaj roped in as new Rohit The upcoming episode of Star Plus popular serial Yeh Rishta Kya Kehlata Hai will showcase interesting drama in ......
About Us | Privacy Policy | Contact Us | Twitter | RSS